Effects of subchronic parathion exposure on cyclosporine pharmacokinetics in rats

Journal of Toxicology and Environmental Health - Part A

Volumn 62, Issue 4, 2001, Pages 289-294

  Gelal, Ayse ^a   Gumustekin, Mukaddes ^a   Kalkan, Sule ^a   Guven, Hulya ^a   Eminoglu, Ozlem ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PARATHION;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INSECTICIDES; LIVER; MALE; PARATHION; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0035936878     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/009841001459441     Document Type: Article

References (16)

1. Arterberry, J. D., Bonifaci, R. W., Nash, E. W., and Quinby, G. E. 1962. Potentiation of phosphorus insecticides by phenothiazine derivatives: Possible hazard, with report a fatal case. J. Am. Med. Assoc. 182:848.
2. Budavari, S., Maryadele, O. N., Smith, A., and Heckelman, P. E. 1989. The Merck index, An encyclopedia of chemicals, and biologicals, 11th ed., p. 960. Rahway, NJ: Merck & Co.
3. Butler, A. M., and Murray, M. 1993. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion. J. Pharmacol. Exp. Ther. 43:902-908.
4. Butler, A. M., and Murray, M. 1997. Biotransformation of parathion in human liver: Participation of CYP3A4 and its inactivation during microsomal parathion oxidation. J. Pharmacol. Exp. Ther. 280: 966-973.
5. Clegg, D. J., and Van Gemert, M. 1999. Expert panel report on human studies on chloropyrifos and/or other organophosphate exposures. J. Toxicol. Environ. Health B 2:257-279.
6. De Matteis, F. 1974. Covalent binding of sulfur to microsomes and loss of cytochrome P-450 during the oxidative desulfiration of several chemicals. Mol. Pharmacol. 10:849-854.
7. Eigenberg, D. A., Pazdernik, T. L., and Doull, J. 1983. Hemoperfusion and pharmacokinetic studies with parathion and paraoxon in the rat and dog. Drug Metab. Dispos. 11:366-370.
8. Fahr, A. 1993. Cyclosporine clinical pharmacokinetics. Clin. Pharmacokinet. 24:472-495.
9. Hunter, A., and Neal, R. A. 1975. Inhibition of hepatic mixed-function oxidase activity in in vitro and in vivo by various thiono-sulfur-containing compounds. Biochem. Pharmacol. 24:2199-2205.
10. Mauer, G., Loosli, H. R., Schreier, E., and Keller, B. 1984. Disposition of cyclosporine in several animal species and man. I. Structural elucidations of its metabolites. Drug Metab. Dispos. 12:120-126.
11. Morelli, M., and Nakatsugawa, T. 1978. Inactivation in vitro of microsomal oxidases during parathion metabolism. Biochem. Pharmacol. 27:293-299.
12. Murray, M., and Reidy, G. F. 1990. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42:85-101.
13. Tuncok, Y., Guven, H., Gelal, A., Apaydin, S., Gidener, S., and Fowler, J. 1995. Poisonings reported to the DPIC in Izmir, Turkey 1994. Toxicol. Lett. 78(suppl.).
14. Vodela, J. K., and Dalvi, R. R. 1995. Comparative toxicological studies of chlorpyrifos in rats and chickens. Vet. Hum. Toxicol. 37:1-3.
15. Yee, G. C., and McGuire, T. R. 1990a. Pharmacokinetic drug interactions with cyclosporine. Clin. Pharmacokinet. 19:319-332.
16. Yee, G. C., and McGuire, T. R. 1990b. Pharmacokinetic drug interactions with cyclosporine. Clin. Pharmacokinet. 19:400-415.